Metelimumab

A4DAB169 | Phase-II
TGFB1
G4 / None
Cambridge Antibody Technology
Phase-II
Whole mAb
CAT-192 CAT192 CAT 192
—
Avg A4D Score
-0.7082
Score Range
-0.74 to -0.67
Structures
5
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB169_6anp_H_L 6anp 99% -0.7076 6.5 4.0 -0.5279 -0.758
A4DAB169_6amj_B_A 6amj 100% -0.7379 7.0 4.0 -0.5663 -0.7832
A4DAB169_6amm_H_L 6amm 100% -0.7215 7.0 4.0 -0.532 -0.771
A4DAB169_6anp_B_A 6anp 99% -0.7066 6.5 4.0 -0.4942 -0.7624
A4DAB169_6amj_H_L 6amj 100% -0.6674 6.5 4.0 -0.4651 -0.7225